Athira Pharma, Inc. ATHA on Nasdaq
This company's Exchange Act registration has been revoked
This company's Exchange Act registration as a Municipal Advisor has been revoked
This company's Exchange Act registration as a Municipal Advisor has been cancelled
[+] Company Information
CIK:
0001620463
0001620463
EIN:
45-3368487
45-3368487
LEI:
(CF Office: 03 Life Sciences)
Business address:
18706 NORTH CREEK PARKWAY, SUITE 104, BOTHELL, WA, 98011
Phone: (425) 620-8501
18706 NORTH CREEK PARKWAY, SUITE 104, BOTHELL, WA, 98011
Phone: (425) 620-8501
Mailing address:
18706 NORTH CREEK PARKWAY, SUITE 104, BOTHELL, WA, 98011
18706 NORTH CREEK PARKWAY, SUITE 104, BOTHELL, WA, 98011
Category:
Non-accelerated filer
Smaller reporting company
Emerging growth company
Non-accelerated filer
Smaller reporting company
Emerging growth company
Former names:
- M3 Biotechnology, Inc. - filings through 2019-01-23
Filings:
337 EDGAR filings since October 3, 2014
337 EDGAR filings since October 3, 2014
Get insider transactions
for this issuer
Get insider transactions
for this reporting owner
Latest Filings (excluding insider transactions)
- February 27, 2025 - S-8: Securities to be offered to employees in employee benefit plans Open documentClick to Open document FilingOpen filingClick to Open filing
- February 27, 2025 - 10-K: Annual report for year ending December 31, 2024Open documentClick to Open document FilingOpen filingClick to Open filing
- February 27, 2025 - 8-K: Current report Open documentClick to Open document FilingOpen filingClick to Open filing **Earnings release**
- 2.02 - Results of Operations and Financial Condition
- 7.01 - Regulation FD Disclosure
- 9.01 - Financial Statements and Exhibits
- February 14, 2025 - SCHEDULE 13G/A: Schedule filed by certain investors to report beneficial ownership of more than 5% of a class of equity securities - amendmentOpen documentClick to Open document FilingOpen filingClick to Open filing
- February 14, 2025 - SCHEDULE 13G/A: Schedule filed by certain investors to report beneficial ownership of more than 5% of a class of equity securities - amendmentOpen documentClick to Open document FilingOpen filingClick to Open filing
Selected Filings
[+] 8-K (current reports)
- February 27, 2025 - 8-K: Current report Open documentClick to Open document FilingOpen filingClick to Open filing **Earnings release**
- 2.02 - Results of Operations and Financial Condition
- 7.01 - Regulation FD Disclosure
- 9.01 - Financial Statements and Exhibits
[+] 10-K (annual reports) and 10-Q (quarterly reports)
- February 27, 2025 - 10-K: Annual report for year ending December 31, 2024Open documentClick to Open document FilingOpen filingClick to Open filing
- November 7, 2024 - 10-Q: Quarterly report for quarter ending September 30, 2024Open documentClick to Open document FilingOpen filingClick to Open filing
- August 9, 2024 - 10-Q/A: Quarterly report for quarter ending June 30, 2024 - amendmentOpen documentClick to Open document FilingOpen filingClick to Open filing
- August 1, 2024 - 10-Q: Quarterly report for quarter ending June 30, 2024Open documentClick to Open document FilingOpen filingClick to Open filing
- May 15, 2024 - 10-Q: Quarterly report for quarter ending March 31, 2024Open documentClick to Open document FilingOpen filingClick to Open filing
[+] Proxy (annual meeting) and information statements
- April 9, 2024 - DEF 14A: Other definitive proxy statements Open documentClick to Open document FilingOpen filingClick to Open filing
[+] Ownership disclosures
- Insider transactions
- March 12, 2025 - 4/A: Statement of changes in beneficial ownership of securities - amendmentOpen documentClick to Open document FilingOpen filingClick to Open filing
- March 4, 2025 - 4: Statement of changes in beneficial ownership of securities Open documentClick to Open document FilingOpen filingClick to Open filing
- March 4, 2025 - 4: Statement of changes in beneficial ownership of securities Open documentClick to Open document FilingOpen filingClick to Open filing
- Beneficial ownership (Schedule 13D and 13G)
- February 14, 2025 - SCHEDULE 13G/A: Schedule filed by certain investors to report beneficial ownership of more than 5% of a class of equity securities - amendmentOpen documentClick to Open document FilingOpen filingClick to Open filing
- February 14, 2025 - SCHEDULE 13G/A: Schedule filed by certain investors to report beneficial ownership of more than 5% of a class of equity securities - amendmentOpen documentClick to Open document FilingOpen filingClick to Open filing
- November 14, 2024 - SC 13G/A: Statement of acquisition of beneficial ownership by individuals - amendmentOpen documentClick to Open document FilingOpen filingClick to Open filing
Filings
| Form type | Form description | Filing date | Reporting date |
|---|
0
Showing 1 to 25 of 337 entries
Data source:
CIK0001620463.json
There is no filings data for
this organization
Investor Resources
How to Use EDGAR
Learn how to use EDGAR to research public filings by public companies, mutual funds, ETFs, some annuities, and more.
Before you Invest, Investor.gov
Get answers to your investing questions from the SEC's website dedicated to retail investors
